Hormonal belly: what your body shape really tells you about your hormones

Most advice on hormonal belly fat lists the same causes: cortisol, menopause, thyroid, stress. The standard framing treats hormonal imbalance weight gain as though one or more hormones go wrong and fat accumulates around the midsection as a result.

That framing is incomplete. It never explains why those hormones are disrupted in the first place, or why different women store fat in completely different patterns. It treats the hormonal imbalance as the starting point, when in most cases it is a consequence of something further upstream.

A hormonal belly is abdominal fat accumulation driven by a disrupted hormonal environment, most commonly chronically elevated insulin from a diet high in processed food and refined carbohydrates. The insulin elevation suppresses sex hormone binding globulin, shifts the balance of estrogen and testosterone, and directs fat storage toward the abdomen. That mechanism is upstream of everything else.

I have spent over a decade reading the research on metabolic health, and working with people who are trying to make sense of what is happening with their bodies. Genetics determines a significant part of where you store fat, and that baseline varies between individuals. But the hormonal environment that sits on top of that baseline is largely shaped by diet, and that is the part you can change. When you understand the relationship between genetics, diet, insulin, sex hormones, and body fat distribution, the path forward becomes clearer.

What your body shape actually tells you

Where your body stores fat is not random, but it is not entirely within your control either. A significant part of the answer is genetic.

Research consistently shows that 30 to 60 percent of the variation in body fat distribution between individuals is heritable. A 2019 review in the International Journal of Obesity found that waist-to-hip ratio heritability falls in this range across populations. A study published in Nature documented significant genetic influence on regional body fat distribution independent of overall body fatness. And a 2021 analysis confirmed that the balance between visceral and subcutaneous fat storage is itself substantially genetically determined.

In practice, two women eating the same diet under the same conditions will not necessarily carry fat in the same places. A naturally narrow-framed woman may gain weight and still look relatively proportioned. A woman genetically predisposed to store fat in her hips and thighs will carry weight there regardless. The narrow-framed woman is not necessarily healthier. She may simply look it.

That genetic baseline is real and it is significant. What this article is about is the modifiable part: the hormonal and metabolic environment that sits on top of that baseline and determines how the pattern is expressed, how much fat you carry, and where the balance shifts.

On that modifiable side, the research is clear. A 2014 review in BioMed Research International described how estrogen and testosterone differentially affect adipocyte physiology and fat distribution. Estrogen promotes subcutaneous fat storage in the hips and thighs. Testosterone promotes visceral fat accumulation. When estrogen declines, fat distribution shifts toward the abdomen.

A 1992 study in the Journal of Clinical Endocrinology & Metabolism examined the relative contributions of androgens and insulin in determining abdominal fat distribution in premenopausal women. Both elevated androgens and elevated insulin independently contributed to central fat accumulation. The combination was worse than either alone.

Most people notice the pattern without understanding the mechanism: body shape shifts at puberty, during pregnancy, and at menopause. All points of major hormonal change. Those shape changes are not cosmetic side effects. They are direct expressions of the hormonal environment at each stage.

Body shape is one of the most underused indicators of what is happening inside. A woman carrying fat predominantly around the abdomen is in a different hormonal and metabolic state from a woman carrying the same amount of fat in her hips and thighs. Two women at the same weight, same body mass index, with completely different risk profiles. Conventional advice treats them the same. They are not.

Understanding which pattern you carry, and what is driving it, changes the conversation about what to do about it. Most advice jumps straight to "lose weight" without asking where the weight is or why it is distributed that way.

How processed food rewires your hormones

Most hormonal belly advice ignores the dietary mechanism entirely.

When carbohydrate intake is high in the context of processed food, excess energy intake, or existing metabolic dysfunction, the liver increases its conversion of carbohydrate into fat through a process called de novo lipogenesis. This is not simply a function of how many carbohydrates you eat. Populations consuming predominantly whole-food carbohydrate diets, such as the traditional yam-based diets in parts of Papua New Guinea, do not typically develop the same metabolic patterns. The difference is the broader context: food quality, insulin sensitivity, and overall metabolic health. A 2005 study in the Journal of Clinical Investigation found that de novo lipogenesis accounted for roughly 26 percent of liver triglycerides in patients with non-alcoholic fatty liver disease, compared to less than 5 percent in healthy controls. Under conditions of metabolic dysfunction, the liver was converting carbohydrate to fat at five times the normal rate.

I have written about the liver mechanism in detail and how it connects to metabolic dysfunction more broadly. The relevant point here is what happens next in the hormonal chain.

When de novo lipogenesis runs chronically, insulin stays elevated. Most people eating a modern processed diet have insulin elevated for most of their waking hours, especially if they eat frequently. Chronically elevated insulin does not just drive fat storage. It directly disrupts sex hormone balance.

A 2013 review in Clinical Endocrinology detailed the relationship between insulin resistance and sex hormone binding globulin (SHBG). SHBG is the protein that binds sex hormones in the blood and regulates how much free hormone is available to tissues. When insulin is high, SHBG production in the liver drops. When SHBG drops, the balance of free estrogen and testosterone changes. The review described SHBG as intimately linked to insulin resistance, with low SHBG levels both reflecting and worsening the metabolic dysfunction.

In women, this typically means more free testosterone relative to estrogen. In men, the pattern reverses. Both produce specific and visible changes in body fat distribution.

Put simply: processed food and excess carbohydrates cause the liver to convert sugar to fat, which keeps insulin chronically elevated, which drives SHBG down and shifts the balance of sex hormones, which changes where fat is stored. The dietary input is the starting point, not the hormonal disruption.

Conventional dietary advice, built around grains, low-fat products, and frequent meals, keeps insulin elevated for most of the day. That alone is enough to shift the hormonal environment toward the patterns I describe below.

Three body fat patterns and what they mean

Female body fat distribution falls broadly into three patterns. Each reflects a different hormonal profile, and each tells you something different about metabolic health. Genetics predisposes which pattern you tend toward. Hormones and diet determine how that baseline is expressed.

Gynoid: subcutaneous, all-over distribution

Fat stored under the skin, distributed relatively evenly or concentrated in the arms, trunk, and hips. This pattern is associated with higher estrogen, higher progesterone, and moderate insulin.

It is the pattern most women carry naturally when metabolic health is reasonable. It is also, from a metabolic risk standpoint, the least dangerous when overweight. Subcutaneous fat does not carry the same metabolic risk as visceral fat. A woman carrying extra weight in a gynoid fat distribution is generally in a better metabolic position than one carrying the same weight around the abdomen.

That does not make the pattern benign at any size. But the hormonal environment behind it is different from the one driving visceral fat, and the risk profile is different too. Historically, subcutaneous fat had a protective function in cold climates. It is insulation. From a purely metabolic standpoint, it is the least concerning of the three patterns.

Lipedema: lower body concentration

Fat concentrated in the buttocks, hips, thighs, and lower legs, often with a noticeably thinner upper body. This pattern is associated with high estrogen, low progesterone, and low testosterone, and it has a strong genetic component.

A 2021 review in the International Journal of Molecular Sciences described lipedema as a painful fat disorder affecting roughly 11 percent of the female population, characterised by bilateral, disproportionate accumulation of subcutaneous adipose tissue in the lower extremities. The review described the hormonal connection, noting that lipedema onset or worsening frequently coincides with hormonal transition points: puberty, pregnancy, and menopause.

In its earlier stages, lipedema is metabolically relatively stable. The fat is subcutaneous rather than visceral, and metabolic markers can remain within acceptable ranges. It becomes more problematic at advanced stages when lymphatic involvement develops. In my experience, women with this pattern can be extremely efficient at converting what they eat to fat, which makes the dietary connection particularly relevant.

The hormonal trigger points are telling. Puberty, pregnancy, and menopause are all periods of major estrogen fluctuation. That the condition worsens at each of these transitions points back to the hormonal mechanism.

Android: visceral, intra-abdominal fat

Fat stored inside the abdominal cavity, around the organs, and sometimes in the chest, neck, and jowls. In women, this is the hormonal belly pattern, and it is associated with low estrogen, high testosterone, and high insulin.

A 2015 review in Obesity Reviews connected sex hormone imbalances directly to visceral adipose tissue dysfunction and metabolic syndrome. The review described how the hormonal environment that promotes visceral fat storage also drives the metabolic complications associated with it: cardiovascular risk, insulin resistance, and inflammatory markers.

This is the pattern most strongly linked to metabolic disease: insulin resistance, type 2 diabetes, and cardiovascular risk. A 2013 review in Thrombosis and Haemostasis described how the metabolic alterations associated with central obesity promote a procoagulant state. In women, it is the pattern most commonly seen alongside polycystic ovary syndrome. When a woman has hormonal belly fat, what is driving it is not randomness. It is a specific hormonal profile, dominated by insulin and testosterone, directing fat to the abdomen. That is why the phrase estrogen belly fat is misleading. It is not high estrogen causing the abdominal fat. It is low estrogen, driven by insulin disrupting the normal hormone balance.

The android vs gynoid fat distinction is not just about appearance. It reflects fundamentally different hormonal and metabolic states. Understanding which pattern you carry changes what the appropriate response is.

The PCOS connection

Polycystic ovary syndrome affects a significant proportion of women of reproductive age. The hormonal profile behind it is the same one that produces the android fat distribution pattern described above: low estrogen, high testosterone, high insulin.

A 2023 review in Clinical and Experimental Medicine described PCOS as a common endocrine disorder characterised by chronic ovulation dysfunction and overabundance of androgens, with insulin resistance present across various tissues as a central feature. The review documented how insulin resistance in the ovaries amplifies androgen production, creating a self-reinforcing cycle.

The mechanism is specific. When insulin is chronically elevated, it stimulates the ovaries to produce testosterone directly. A 1998 study in the Journal of Clinical Endocrinology & Metabolism demonstrated that insulin stimulates testosterone biosynthesis in human thecal cells from women with PCOS by activating its own receptor on those cells. Insulin is not just a bystander in PCOS. It is an active driver of the testosterone excess.

What follows from there is predictable. High testosterone, low estrogen, no normal estrogen-progesterone cycling. Eggs develop but do not release properly, menstrual cycles become irregular or absent, and fertility drops.

When insulin is driving the testosterone excess, the most effective intervention addresses insulin. A 2019 meta-analysis in the International Journal of Endocrinology reviewed randomised controlled trials on low-carbohydrate diets in women with PCOS and found improvements in body mass, insulin resistance, and hormonal markers. The meta-analysis recommended low-carbohydrate diets particularly for PCOS with insulin resistance.

In conversations with people dealing with this, the pattern is consistent: when women with PCOS reduce their carbohydrate intake significantly and remove processed food, hormonal markers begin to shift. Cycles become more regular, and in some cases fertility improves. This is consistent with the mechanism. Remove the insulin stimulus, and ovarian testosterone production reduces. Estrogen and progesterone begin to cycle normally. I am not suggesting this is simple or that everyone responds identically. But the direction of the research is clear, and the dietary connection to PCOS through insulin is among the better documented hormonal pathways in the literature.

Why visceral fat is the warning sign, not the cause

Most hormonal belly advice treats abdominal fat as the problem itself. Belly fat causes heart disease, belly fat causes metabolic syndrome, belly fat is dangerous. The framing puts the fat at the centre and then tells you to get rid of it.

Visceral fat is the indicator, not the driver. The same metabolic environment that directs fat to the abdomen, high insulin, disrupted sex hormones, chronic metabolic stress, also damages the cardiovascular system independently.

A 2009 study in Obesity examining the Study of Women's Health Across the Nation found that testosterone levels predicted visceral fat accumulation in midlife women independently of other factors. The hormonal profile comes first. The fat distribution follows.

If visceral fat were the primary cause of cardiovascular damage, removing the fat should fix the problem. A 2004 study in the New England Journal of Medicine found that abdominal liposuction did not significantly improve metabolic abnormalities. Calorie restriction can reduce overall weight, but if the hormonal environment has not changed, the body continues to preferentially store fat in the same pattern. I have written about why belly fat resists conventional approaches and the metabolic lock that keeps it in place.

In my experience, when people address the metabolic dysfunction driving visceral fat, the cardiovascular markers improve alongside the body composition changes. Not because the fat left, but because the metabolic environment shifted. Fat loss is a consequence of that shift, not the cause of it.

Hormonal belly fat is a downstream consequence. Fixing the downstream effect without addressing the upstream cause is why so many people stay stuck despite genuine effort.

What actually changes the pattern

For the hormonal weight gain women experience around menopause, midlife, or alongside PCOS, they are typically told to manage stress, sleep better, consider hormone replacement, and exercise. Those all have a role. But the primary lever, the one that addresses the mechanism actually driving the hormonal disruption in most cases, is diet.

Remove the processed food and the excess refined carbohydrates. When the dietary inputs that are driving chronic insulin elevation stop, insulin sensitivity begins to improve. As insulin drops, SHBG rises, sex hormone balance shifts, and over time fat distribution starts to change.

This is the mechanism described by the research cited throughout this article, and it is consistent with what I have seen working with people over the years. Someone who has had insulin resistance building for two decades is not going to see changes in the same timeframe as someone six months into the problem. Different body shapes respond at different rates, the severity of the hormonal disruption varies, and genetic predisposition means not everyone will shift into the same pattern even when the metabolic environment improves. But the direction of change is the same for everyone, and the metabolic health improvements happen regardless of whether the visible body shape change is dramatic or subtle.

The shift does not need to be dramatic overnight. It starts with removing the obvious: ultra-processed food, soft drinks, added sugar, and the refined seed oils that are in almost everything. Build meals around protein and whole food. Create gaps between meals so insulin has time to drop. Movement helps, sleep is essential, and stress management is part of it. But none of those will override a diet that is still driving the problem. Fix the food first.

I have written about what foundational health actually means and why the dietary base has to come first. I have also written about the ancestral approach to eating that has been the foundation of my own health for over twelve years. The principles are the same regardless of which body fat pattern you are starting from: stop feeding the process that is driving the hormonal disruption, and give the body the conditions it needs to regulate itself.

Hormonal belly fat is not a cosmetic problem with a cosmetic solution. It is a metabolic problem with a dietary solution. The body shape you see in the mirror is telling you something about what is happening inside, filtered through your genetic baseline. When the hormonal environment changes, the metabolic health improves, and the body composition follows.